[99mTc]Tc-DB15 in GRPR-Targeted Tumor Imaging with SPECT: From Preclinical Evaluation to the First Clinical Outcomes

Berthold A. Nock, Aikaterini Kaloudi, Panagiotis Kanellopoulos, +5

Cancers

One Step Closer to Clinical Translation: Enhanced Tumor Targeting of [99mTc]Tc-DB4 and [111In]In-SG4 in Mice Treated with Entresto

Panagiotis Kanellopoulos, Aikaterini Kaloudi, Maritina Rouchota, +4

Pharmaceutics

Comparative evaluation of the new GRPR‐antagonist ¹¹¹In‐SB9 and ¹¹¹In‐AMBA in prostate cancer models: Implications of in vivo stability

Emmanouil Lymperis, Aikaterini Kaloudi, Panagiotis Kanellopoulos, +3

Journal of Labelled Compounds and Radiopharmaceuticals

Comparing Gly11/dAla11-Replacement vs. the in-Situ Neprilysin-Inhibition Approach on the Tumor-targeting Efficacy of the 111In-SB3/111In-SB4 Radiotracer Pair

Emmanouil Lymperis, Aikaterini Kaloudi, Panagiotis Kanellopoulos, +3

Molecules

Key-Protease Inhibition Regimens Promote Tumor Targeting of Neurotensin Radioligands

Panagiotis Kanellopoulos, Aikaterini Kaloudi, Marion de Jong, +2

Pharmaceutics

[^99mTc]Tc-DGA1, a Promising CCK₂R-Antagonist-Based Tracer for Tumor Diagnosis with Single-Photon Emission Computed Tomography

Aikaterini Kaloudi, Panagiotis Kanellopoulos, Thorsten Radolf, +6

Molecular Pharmaceutics

[99mTc]Tc-DB1 Mimics with Different-Length PEG Spacers: Preclinical Comparison in GRPR-Positive Models

Panagiotis Kanellopoulos, Emmanouil Lymperis, Aikaterini Kaloudi, +3

Molecules

[68Ga]Ga-DATA5m-LM4, a PET Radiotracer in the Diagnosis of SST2R-Positive Tumors: Preclinical and First Clinical Results

Panagiotis Kanellopoulos, Berthold A. Nock, Lukas Greifenstein, +2

International Journal of Molecular Sciences

Optimizing the Profile of [99mTc]Tc–NT(7–13) Tracers in Pancreatic Cancer Models by Means of Protease Inhibitors

Panagiotis Kanellopoulos, Berthold A. Nock, Eric P. Krenning

International Journal of Molecular Sciences

Nonpeptidic Z360-Analogs Tagged with Trivalent Radiometals as Anti-CCK2R Cancer Theranostic Agents: A Preclinical Study

Berthold A. Nock, Panagiotis Kanellopoulos, Oleg G. Chepurny, +4

Pharmaceutics